Characteristics and challenges of the clinical pipeline of digital therapeutics.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33311567.
- Also identified by DOI 10.1038/s41746-020-00370-8 and PMC identifier 7733514.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In this Comment, we characterize the current pipeline of digital therapeutics and offer a clinical perspective into the advantages, challenges, and barriers to implementation of this treatment modality for patient care, which we hope will inform future regulatory policy, prescribing decisions, and scope of real-world evidence collection.